Perspectivep. 122-123

Double danger: The peril of childbirth for women with rheumatic heart disease

Author(s): Stuart L Silverman

DOI: 10.37532/1758-4272.2022.17(6).122-123

• Full-Text
• PDF

Short Communicationp. 124-125

Denosumab does not increase infection risk in rheumatic disease patients when used alone or in combination with biologic dmards

Author(s): Silvano Adami

DOI: 10.37532/1758-4272.2022.17(6).124-125

• Full-Text
• PDF

Short Communicationp. 128-129

COVID-19 infection rates low in people with rheumatic diseases, most report mild illness

Author(s): Ronald A Asherson

DOI: 10.37532/1758-4272.2022.17(6).128-129

• Full-Text
• PDF

Commentaryp. 130-131

Rheumatic fever and household overcrowding

Author(s): TJ Martin

DOI: 10.37532/1758-4272.2022.17(6).130-131

• Full-Text
• PDF

Opinion Articlep. 126-127

Potential target for treating osteoporosis

Author(s): Rene Westhovens

DOI: 10.37532/1758-4272.2022.17(6).126-127

• Full-Text
• PDF